1. Home
  2. OCUL vs CGBD Comparison

OCUL vs CGBD Comparison

Compare OCUL & CGBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • CGBD
  • Stock Information
  • Founded
  • OCUL 2006
  • CGBD 2012
  • Country
  • OCUL United States
  • CGBD United States
  • Employees
  • OCUL N/A
  • CGBD N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • CGBD Finance: Consumer Services
  • Sector
  • OCUL Health Care
  • CGBD Finance
  • Exchange
  • OCUL Nasdaq
  • CGBD Nasdaq
  • Market Cap
  • OCUL 957.3M
  • CGBD 1.0B
  • IPO Year
  • OCUL 2014
  • CGBD 2017
  • Fundamental
  • Price
  • OCUL $7.06
  • CGBD $13.67
  • Analyst Decision
  • OCUL Strong Buy
  • CGBD Hold
  • Analyst Count
  • OCUL 10
  • CGBD 3
  • Target Price
  • OCUL $16.11
  • CGBD $14.00
  • AVG Volume (30 Days)
  • OCUL 1.6M
  • CGBD 404.4K
  • Earning Date
  • OCUL 05-05-2025
  • CGBD 05-06-2025
  • Dividend Yield
  • OCUL N/A
  • CGBD 12.94%
  • EPS Growth
  • OCUL N/A
  • CGBD N/A
  • EPS
  • OCUL N/A
  • CGBD 1.31
  • Revenue
  • OCUL $59,647,000.00
  • CGBD $225,447,000.00
  • Revenue This Year
  • OCUL $13.32
  • CGBD $4.34
  • Revenue Next Year
  • OCUL $13.13
  • CGBD $2.48
  • P/E Ratio
  • OCUL N/A
  • CGBD $10.48
  • Revenue Growth
  • OCUL N/A
  • CGBD N/A
  • 52 Week Low
  • OCUL $4.06
  • CGBD $13.12
  • 52 Week High
  • OCUL $11.78
  • CGBD $18.74
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 44.18
  • CGBD 35.35
  • Support Level
  • OCUL $6.84
  • CGBD $13.32
  • Resistance Level
  • OCUL $8.90
  • CGBD $14.95
  • Average True Range (ATR)
  • OCUL 0.47
  • CGBD 0.40
  • MACD
  • OCUL -0.11
  • CGBD -0.02
  • Stochastic Oscillator
  • OCUL 10.71
  • CGBD 19.13

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About CGBD Carlyle Secured Lending Inc.

Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.

Share on Social Networks: